Literature DB >> 30485243

Transcortical insular glioma resection: clinical outcome and predictors.

N U Farrukh Hameed1, Tianming Qiu1, Dongxiao Zhuang1, Junfeng Lu1, Zhengda Yu1, Shuai Wu1, Bin Wu1, Fengping Zhu1, Yanyan Song2, Hong Chen3, Jinsong Wu1.   

Abstract

OBJECTIVE: Insular lobe gliomas continue to challenge neurosurgeons due to their complex anatomical position. Transcortical and transsylvian corridors remain the primary approaches for reaching the insula, but the adoption of one technique over the other remains controversial. The authors analyzed the transcortical approach of resecting insular gliomas in the context of patient tumor location based on the Berger-Sinai classification, achievable extents of resection (EORs), overall survival (OS), and postsurgical neurological outcome.
METHODS: The authors studied 255 consecutive cases of insular gliomas that underwent transcortical tumor resection in their division. Tumor molecular pathology, location, EOR, postoperative neurological outcome for each insular zone, and the accompanying OS were incorporated into the analysis to determine the value of this surgical approach.
RESULTS: Lower-grade insular gliomas (LGGs) were more prevalent (63.14%). Regarding location, giant tumors (involving all insular zones) were most prevalent (58.82%) followed by zone I+IV (anterior) tumors (20.39%). In LGGs, tumor location was an independent predictor of survival (p = 0.003), with giant tumors demonstrating shortest patient survival (p = 0.003). Isocitrate dehydrogenase 1 (IDH1) mutation was more likely to be associated with giant tumors (p < 0.001) than focal tumors located in a regional zone. EOR correlated with survival in both LGG (p = 0.001) and higher-grade glioma (HGG) patients (p = 0.008). The highest EORs were achieved in anterior-zone LGGs (p = 0.024). In terms of developing postoperative neurological deficits, patients with giant tumors were more susceptible (p = 0.038). Postoperative transient neurological deficit was recorded in 12.79%, and permanent deficit in 15.70% of patients. Patients who developed either transient or permanent postsurgical neurological deficits exhibited poorer survival (p < 0.001).
CONCLUSIONS: The transcortical surgical approach can achieve maximal tumor resection in all insular zones. In addition, the incorporation of adjunct technologies such as multimodal brain imaging and mapping of cortical and subcortical eloquent brain regions into the transcortical approach favors postoperative neurological outcomes, and prolongs patient survival.

Entities:  

Keywords:  ASPI = anterior, superior, posterior, or inferior; CI = confidence interval; DTI = diffusion tensor imaging; EOR = extent of resection; GTR = gross-total resection; HGG = higher-grade glioma; HR = hazard ratio; IDH1 = isocitrate dehydrogenase 1; LGG = lower-grade glioma; MEP = motor evoked potential; OS = overall survival; PFS = progression-free survival; PI = proliferative index; STR = subtotal resection; classification; glioma; insula; oncology; prognosis; surgery

Mesh:

Year:  2018        PMID: 30485243     DOI: 10.3171/2018.4.JNS18424

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  10 in total

1.  Prediction of Lower Grade Insular Glioma Molecular Pathology Using Diffusion Tensor Imaging Metric-Based Histogram Parameters.

Authors:  Zhenxing Huang; Changyu Lu; Gen Li; Zhenye Li; Shengjun Sun; Yazhuo Zhang; Zonggang Hou; Jian Xie
Journal:  Front Oncol       Date:  2021-03-10       Impact factor: 6.244

2.  Tumor location-based classification of surgery-related language impairments in patients with glioma.

Authors:  Shengyu Fang; Yuchao Liang; Lianwang Li; Lei Wang; Xing Fan; Yinyan Wang; Tao Jiang
Journal:  J Neurooncol       Date:  2021-10-01       Impact factor: 4.130

3.  Vessel Size Imaging is Associated with IDH Mutation and Patient Survival in Diffuse Lower-Grade Glioma.

Authors:  Houyi Kang; Peng Chen; Hong Guo; Letian Zhang; Yong Tan; Hualiang Xiao; Ao Yang; Jingqin Fang; Weiguo Zhang
Journal:  Cancer Manag Res       Date:  2020-10-08       Impact factor: 3.989

Review 4.  Surgical strategy for insular glioma.

Authors:  Colin J Przybylowski; Shawn L Hervey-Jumper; Nader Sanai
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

5.  Multimodal integrated approaches in low grade glioma surgery.

Authors:  Tamara Ius; Edoardo Mazzucchi; Barbara Tomasino; Giada Pauletto; Giovanni Sabatino; Giuseppe Maria Della Pepa; Giuseppe La Rocca; Claudio Battistella; Alessandro Olivi; Miran Skrap
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

6.  Challenging Giant Insular Gliomas With Brain Mapping: Evaluation of Neurosurgical, Neurological, Neuropsychological, and Quality of Life Results in a Large Mono-Institutional Series.

Authors:  Marco Rossi; Lorenzo Gay; Marco Conti Nibali; Tommaso Sciortino; Federico Ambrogi; Antonella Leonetti; Guglielmo Puglisi; Henrietta Howells; Paola Zito; Federico Villa; Gjulio Ciroi; Marco Riva; Lorenzo Bello
Journal:  Front Oncol       Date:  2021-03-22       Impact factor: 6.244

7.  Awake Surgery for Left Posterior Insular Low-Grade Glioma Through the Parietorolandic Operculum: The Need to Preserve the Functional Connectivity. A Case Series.

Authors:  Hugues Duffau
Journal:  Front Surg       Date:  2022-01-13

8.  Surgical techniques and function outcome for cingulate gyrus glioma, how we do it.

Authors:  Fangyuan Gong; Lei Jin; Qiuwei Song; Zhong Yang; Hong Chen; Jinsong Wu
Journal:  Front Oncol       Date:  2022-09-26       Impact factor: 5.738

9.  Sensitivity of three-dimensional time-of-flight 3.0 ​T magnetic resonance angiography in visualizing the number and course of lenticulostriate arteries in patients with insular gliomas.

Authors:  Andrey E Bykanov; David I Pitskhelauri; Artem I Batalov; Robert Young; Maxim A Trube; Andrei I Holodny; Igor N Pronin; Timur Zagidullin
Journal:  Brain Spine       Date:  2021-12-21

10.  The role of lateralisation and sex on insular cortex: 3D volumetric analysis

Authors:  Fatma Öz; Niyazi Acer; Nihan Katayıfçı; Güneş Aytaç; Kamil Karaali; Muzaffer Sindel
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.